Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 8.14 USD 0.25% Market Closed
Market Cap: 39.4m USD
DXR
/
Income Statement
/
Revenue

Daxor Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daxor Corp
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Daxor Corp
NASDAQ:DXR
Revenue
$119.7k
CAGR 3-Years
-25%
CAGR 5-Years
-21%
CAGR 10-Years
-23%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.6B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$16.7B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Revenue
$22.6B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$42B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$8.4B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
15%

Daxor Corp
Glance View

Market Cap
40.2m USD
Industry
Health Care

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.

DXR Intrinsic Value
3.48 USD
Overvaluation 57%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Daxor Corp's Revenue?
Revenue
119.7k USD

Based on the financial report for Dec 31, 2024, Daxor Corp's Revenue amounts to 119.7k USD.

What is Daxor Corp's Revenue growth rate?
Revenue CAGR 10Y
-23%

Over the last year, the Revenue growth was -27%. The average annual Revenue growth rates for Daxor Corp have been -25% over the past three years , -21% over the past five years , and -23% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.